Apg Asset Management N.V. Boston Scientific Corp Transaction History

Apg Asset Management N.V.

$36.1 Billion
Q4 2024

A detailed history of Apg Asset Management N.V. transactions in Boston Scientific Corp stock. As of the latest transaction made, Apg Asset Management N.V. holds 1,021,217 shares of BSX stock, worth $97.1 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

1,021,217

Previous 202,542 404.2%

Holding current value

$97.1 Million

Previous $17 Million 437.41%

% of portfolio

0.25%

Previous 0.11%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$83.62 - $91.5 $68.5 Million - $74.9 Million	818,675 Added 404.2%	1,021,217 $91.2 Million
Q3 2024 Nov 14, 2024	SELL	$72.96 - $84.0 $79.5 Million - $91.5 Million	-1,089,754 Reduced 84.33%	202,542 $17 Million
Q2 2024 Aug 14, 2024	BUY	$67.33 - $77.71 $20.9 Million - $24.1 Million	310,101 Added 31.57%	1,292,296 $99.5 Million
Q1 2024 May 14, 2024	SELL	$57.6 - $68.62 $5.13 Million - $6.12 Million	-89,132 Reduced 8.32%	982,195 $67.3 Million
Q4 2023 Feb 13, 2024	SELL	$48.64 - $57.81 $2.3 Million - $2.73 Million	-47,219 Reduced 4.22%	1,071,327 $61.9 Million
Q3 2023 Nov 14, 2023	SELL	$50.19 - $54.68 $6.97 Million - $7.59 Million	-138,790 Reduced 11.04%	1,118,546 $59.1 Million
Q2 2023 Aug 14, 2023	SELL	$49.72 - $54.64 $1 Million - $1.1 Million	-20,116 Reduced 1.57%	1,257,336 $68 Million
Q1 2023 May 12, 2023	SELL	$45.09 - $50.03 $9.9 Million - $11 Million	-219,458 Reduced 14.66%	1,277,452 $63.9 Million
Q4 2022 Feb 14, 2023	BUY	$39.56 - $47.22 $46.9 Million - $56 Million	1,185,996 Added 381.45%	1,496,910 $69.3 Million
Q3 2022 Nov 14, 2022	BUY	$36.71 - $109.66 $988,196 - $2.95 Million	26,919 Added 9.48%	310,914 $12.3 Million
Q2 2022 Aug 12, 2022	BUY	$35.24 - $47.1 $4.51 Million - $6.03 Million	128,028 Added 82.09%	283,995 $10.1 Million
Q1 2022 May 12, 2022	SELL	$40.9 - $45.1 $1.12 Million - $1.24 Million	-27,400 Reduced 14.94%	155,967 $6.21 Million
Q4 2021 Feb 11, 2022	SELL	$38.07 - $44.87 $2.9 Million - $3.42 Million	-76,200 Reduced 29.36%	183,367 $6.85 Million
Q3 2021 Nov 15, 2021	BUY	$41.23 - $45.88 $5.47 Million - $6.09 Million	132,700 Added 104.6%	259,567 $9.72 Million
Q2 2021 Aug 13, 2021	SELL	$38.58 - $44.24 $4 Million - $4.58 Million	-103,556 Reduced 44.94%	126,867 $4.57 Million
Q1 2021 May 14, 2021	SELL	$35.27 - $39.67 $13.3 Million - $14.9 Million	-376,583 Reduced 62.04%	230,423 $7.58 Million
Q4 2020 Feb 12, 2021	SELL	$33.15 - $41.97 $12.7 Million - $16.1 Million	-382,692 Reduced 38.67%	607,006 $17.8 Million
Q3 2020 Nov 12, 2020	SELL	$34.44 - $42.23 $1.69 Million - $2.08 Million	-49,181 Reduced 4.73%	989,698 $32.2 Million
Q2 2020 Aug 14, 2020	BUY	$30.19 - $39.11 $1.15 Million - $1.49 Million	38,015 Added 3.8%	1,038,879 $32.5 Million
Q1 2020 May 15, 2020	BUY	$25.83 - $45.71 $16.3 Million - $28.8 Million	629,325 Added 169.38%	1,000,864 $32.7 Million
Q1 2020 May 14, 2020	SELL	$25.83 - $45.71 $3.73 Million - $6.61 Million	-144,525 Reduced 28.01%	371,539 $12.7 Million
Q4 2019 Feb 13, 2020	BUY	$37.87 - $45.37 $2.57 Million - $3.08 Million	67,800 Added 15.13%	516,064 $20.8 Million
Q3 2019 Nov 08, 2019	SELL	$40.31 - $43.45 $1.43 Million - $1.54 Million	-35,375 Reduced 7.31%	448,264 $16.7 Million
Q2 2019 Aug 13, 2019	BUY	$34.91 - $42.98 $3.91 Million - $4.82 Million	112,100 Added 30.17%	483,639 $18.3 Million
Q4 2018 Feb 13, 2019	SELL	$31.73 - $39.04 $1.08 Million - $1.33 Million	-34,100 Reduced 8.41%	371,539 $11.5 Million
Q4 2017 Jan 24, 2018	SELL	$24.79 - $29.8 $3.32 Million - $3.99 Million	-133,785 Reduced 24.8%	405,639 $8.37 Million
Q3 2017 Oct 19, 2017	BUY	$26.26 - $29.17 $14.2 Million - $15.7 Million	539,424	539,424 $15.7 Million

Others Institutions Holding BSX

# of Institutions

1,707

Shares Held

1.19B

Call Options Held

8.76M

Put Options Held

9.43M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $136B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.

Account

Apg Asset Management N.V. Boston Scientific Corp Transaction History